Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial.
Meyer, T Qian, W Valle, Juan W Talbot, D Cunningham, D Reed, N Wall, L Waters, J Ross, P Anthoney, A
Meyer, T
Qian, W
Valle, Juan W
Talbot, D
Cunningham, D
Reed, N
Wall, L
Waters, J
Ross, P
Anthoney, A
Citations
Altmetric:
Abstract
Description
Date
2016-10-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Capecitabine and streptozocin +/- cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial. 2016, 27 (suppl_6):446P Annals of Oncology